VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by snuff69on Mar 14, 2018 10:24am

185 Views

Post# 27712604

RE:VPT Appoints Dr. Samuel Schwartz Chair of Business Advisory

Here’s the letter from George today regarding the news release

Dear Stakeholder;

Attached is a news release announcing Dr. Sam Schwartz has agreed to construct and lead a Business Advisory Committee for the Company.

Here is some background:

1. Sam is a leader in the biotech small-business space and has helped many companies like Ventripoint to expand and prosper though his extensive network of professionals.
2. Sam has had and continues to have a special concern for children as shown by his associations with many agencies addressing children’s issues.
3. Ventripoint is entering a period where it is considering optiosn to expand the business globally through sales and perhaps acquisitions and Sam will be invaluable in helping the company evaluate different opportunities.

Please join me in welcoming Sam to our team.

Regards,

George Adams, PhD, ICD.D
CEO
Ventripoint Diagnostics Ltd..
Cell: 519-803-6937
TSXV: VPT
www.ventripoint.com